
Genomic Analysis of Staphylococcus aureus of the Lineage CC130, Including mecC-Carrying MRSA and MSSA Isolates Recovered of Animal, Human, and Environmental Origins
Paul
- 0
Most methicillin resistant Staphylococcus aureus (MRSA) isolates harboring mecC gene belong to clonal advanced CC130. This lineage has historically been considered animal-associated because it lacks the human particular immune evasion cluster (IEC), and has been recovered from a broad vary of animal hosts. However, sporadic mecC-MRSA human infections have been reported, with proof of zoonotic transmission in some instances.
The target of this research was to research the whole-genome sequences of 18 S. aureus CC130 isolates [13 methicillin-resistant (mecC-MRSA) and five methicillin-susceptible (MSSA)] from totally different sequences sorts, obtained from a wide range of host species and origins (human, livestock, wild birds and mammals, and water), and from totally different geographic places, with a view to determine attribute markers and genomic options. Antibiotic resistance genes discovered amongst MRSA-CC130 had been these related to the SSCmecXI factor. Most MRSA-CC130 strains carried the same virulence gene profile. Moreover, six MRSA-CC130 possessed scn-sak and one MSSA-ST130 had lukMF’.
The MSSA-ST700 strains had been most divergent of their resistance and virulence genes. The pan-genome evaluation confirmed that 29 genes had been current solely in MRSA-CC130 (related to SCCmecXI) and 21 amongst MSSA-CC130 isolates (related to phages). The SCCmecXI, PBP3, GdpP, and AcrB had been an identical on the amino acid degree in all strains, however some variations had been present in PBP1, PBP2, PBP4, and YjbH proteins. An examination of the host markers confirmed that the three’ area of the bacteriophage φ3 was almost an identical to the reference sequence.
Truncated hlb gene was additionally present in scn-negative strains (two of them carrying sak-type gene). The dtlB gene of untamed rabbit isolates included novel mutations. The vwbp gene was discovered within the three MSSA-ST700 strains from small ruminants and in a single MSSA-ST130 from a crimson deer; these strains additionally carried a scn-type gene, totally different from the human and equine variants.
Lastly, a phylogenetic evaluation confirmed that the three MSSA-ST700 strains and the 2 MSSA-ST130 strains cluster individually from the remaining MRSA-CC130 strains with the etD2 gene as marker for the primary lineage. The presence of the human IEC cluster in some mecC-MRSA-CC130 strains means that these isolates might have had a human origin.
Prevalence and genomic investigation of Salmonella isolates recovered from animal food-chain in Xinjiang, China
Salmonella is a serious foodborne pathogen worldwide, inflicting severe instances of morbidity and mortality because of the consumption of contaminated meals. Animal-borne meals had been thought-about the primary supply of transferring Salmonella to people; nonetheless, route surveillance by genomic platforms alongside the food-chain is proscribed in China. Right here, we proceeded to the appliance of complete genome sequencing within the epidemiological evaluation of Salmonella remoted alongside the food-chain in Xinjiang, China. A complete of 2408 samples had been collected from farms, slaughterhouses, and markets, and subjected to the isolation of Salmonella strains. 314 (13.04%) of the samples had been optimistic for Salmonella.
Phenotypic antimicrobial resistance was carried out by the broth dilution technique utilizing 14 antimicrobial brokers belonging to 10 lessons for all 314 isolates. A number of consultant 103 isolates was subjected to whole-genome sequencing for understanding the Salmonella variety, together with serovars, antimicrobial and virulence genes, plasmid sorts, multi-locus sequence sorts, and allelic sorts. We discovered that S. Agona was the dominant serovar and O:4(B) was the dominant serogroup.
The dominant genotype was ST13 and every serovar has a singular MLST sample. Plasmids prediction reported Col(MGD2)_1 and Col(Ye4449)_1 because the dominant plasmids, along with the detection of IncFII(S)_1 and IncFIB(S)_1 carried by all S. Enteritidis isolates. Importantly, virulence genes prediction confirmed the presence of cdtB gene encoding typhoid toxins, spv genes, and pef gene cluster encoding fimbriae within the genomes of S. Indiana and S. Enteritidis. Phenotypic antimicrobial resistance recognized 92.04% of the sampled isolates as multi-drug resistance (MDR), with excessive resistance to tetracycline (78.03%; 245/314), amoxicillin/ clavulanic acid (75.80%; 238/314), and ampicillin (70.70%; 222/314).

Collectively, we firstly reported the prevalence of MDR Salmonella isolates harboring essential virulence elements transmission by way of animal-borne food-chain in Xinjiang, therefore route surveillance by whole-genome sequencing platform might facilitate recognition and venture early warning for the rising MDR clones alongside the food-chain.
Narrative evaluate of the novel coronavirus SARS-CoV-2: replace on genomic traits, transmissions and animal mannequin
Two outbreaks of extreme respiratory an infection brought on by extreme acute respiratory syndrome coronavirus (SARS-CoV) and the Center East respiratory syndrome coronavirus (MERS-CoV) brought about world pandemics and highlighted the significance of preparedness for respiratory CoVs. Lately, a 3rd extremely pathogenic CoV, extreme acute respiratory syndrome coronavirus 2 (SARS-CoV-2), was first recognized in Wuhan, Hubei, China and posed a public well being disaster worldwide.
CD44 Antigen (CD44) Antibody |
|||
20-abx327913 | Abbexa |
|
|
CD44 Antigen (CD44) Antibody |
|||
abx332801-100ul | Abbexa | 100 ul | EUR 510 |
CD44 Antigen (CD44) Antibody |
|||
abx011738-100ug | Abbexa | 100 ug | EUR 526.8 |
CD44 Antigen (CD44) Antibody |
|||
20-abx019050 | Abbexa |
|
|
CD44 Antigen (CD44) Antibody |
|||
abx015801-100ul | Abbexa | 100 ul | EUR 493.2 |
CD44 Antigen (CD44) Antibody |
|||
abx021434-02mg | Abbexa | 0.2 mg | EUR 644.4 |
CD44 Antigen (CD44) Antibody |
|||
abx021435-02mg | Abbexa | 0.2 mg | EUR 644.4 |
CD44 Antigen (CD44) Antibody |
|||
abx025270-400ul | Abbexa | 400 ul | EUR 627.6 |
CD44 Antigen (CD44) Antibody |
|||
abx025270-80l | Abbexa | 80 µl | EUR 343.2 |
CD44 Antigen (CD44) Antibody |
|||
20-abx007560 | Abbexa |
|
|
CD44 Antigen (CD44) Antibody |
|||
20-abx001198 | Abbexa |
|
|
CD44 Antigen (CD44) Antibody |
|||
abx414285-02mg | Abbexa | 0.2 mg | EUR 678 |
CD44 Antigen (CD44) Antibody |
|||
abx414286-25ug | Abbexa | 25 ug | EUR 326.4 |
CD44 Antigen (CD44) Antibody |
|||
abx414875-025mg | Abbexa | 0.25 mg | EUR 678 |
CD44 Antigen (CD44) Antibody |
|||
abx415170-025mg | Abbexa | 0.25 mg | EUR 710.4 |
CD44 Antigen (CD44) Antibody |
|||
abx415396-01mg | Abbexa | 0.1 mg | EUR 526.8 |
CD44 Antigen (CD44) Antibody |
|||
abx415398-025mg | Abbexa | 0.25 mg | EUR 678 |
CD44 Antigen (CD44) Antibody |
|||
abx415399-1mg | Abbexa | 1 mg | EUR 994.8 |
CD44 Antigen (CD44) Antibody |
|||
abx415545-01mg | Abbexa | 0.1 mg | EUR 543.6 |
CD44 Antigen (CD44) Antibody |
|||
abx415612-02mg | Abbexa | 0.2 mg | EUR 678 |
CD44 Antigen (CD44) Antibody |
|||
abx415623-20ug | Abbexa | 20 ug | EUR 326.4 |
CD44 Antigen (CD44) Antibody |
|||
abx412639-025mg | Abbexa | 0.25 mg | EUR 678 |
CD44 Antigen (CD44) Antibody |
|||
abx412640-25ug | Abbexa | 25 ug | EUR 326.4 |
CD44 Antigen (CD44) Antibody |
|||
abx412685-01mg | Abbexa | 0.1 mg | EUR 543.6 |
CD44 Antigen (CD44) Antibody |
|||
abx412739-01mg | Abbexa | 0.1 mg | EUR 543.6 |
CD44 Antigen (CD44) Antibody |
|||
abx413849-01mg | Abbexa | 0.1 mg | EUR 543.6 |
CD44 Antigen (CD44) Antibody |
|||
abx414525-02mg | Abbexa | 0.2 mg | EUR 678 |
CD44 Antigen (CD44) Antibody |
|||
abx414526-25ug | Abbexa | 25 ug | EUR 326.4 |
CD44 Antigen (CD44) Antibody |
|||
20-abx111485 | Abbexa |
|
|
CD44 Antigen (CD44) Antibody |
|||
abx200293-100ug | Abbexa | 100 ug | EUR 393.6 |
CD44 Antigen (CD44) Antibody |
|||
20-abx200798 | Abbexa |
|
|
CD44 Antigen (CD44) Antibody |
|||
20-abx241364 | Abbexa |
|
|
CD44 Antigen (CD44) Antibody |
|||
20-abx242943 | Abbexa |
|
|
CD44 Antigen (CD44) Antibody |
|||
abx122068-100ug | Abbexa | 100 ug | EUR 469.2 |
CD44 Antigen (CD44) Antibody |
|||
20-abx134411 | Abbexa |
|
|
CD44 Antigen (CD44) Antibody |
|||
20-abx137093 | Abbexa |
|
|
CD44 Antigen (CD44) Antibody |
|||
20-abx137102 | Abbexa |
|
|
CD44 Antigen (CD44) Antibody |
|||
20-abx137492 | Abbexa |
|
|
CD44 Antigen (CD44) Antibody |
|||
abx139276-01mg | Abbexa | 0.1 mg | EUR 444 |
CD44 Antigen (CD44) Antibody |
|||
abx139277-01mg | Abbexa | 0.1 mg | EUR 444 |
CD44 Antigen (CD44) Antibody |
|||
abx149089-100ug | Abbexa | 100 ug | EUR 526.8 |
CD44 Antigen (CD44) Antibody |
|||
abx432475-200ul | Abbexa | 200 ul | EUR 460.8 |
Human CD44/ CD44 antigen ELISA Kit |
|||
E0426Hu | Sunlong | 1 Kit | EUR 675.6 |
Human CD44(CD44 antigen) ELISA Kit |
|||
EH0654 | FN Test | 96T | EUR 681.12 |
Description: Method of detection: Double Antibody, Sandwich ELISA;Reacts with: Homo sapiens;Sensitivity: 0.094 ng/ml |
CD44 Antigen (CD44) Antibody (PE) |
|||
abx200295-100tests | Abbexa | 100 tests | EUR 661.2 |
CD44 Antigen (CD44) Antibody (PE) |
|||
20-abx200795 | Abbexa |
|
|
CD44 Antigen (CD44) Antibody (PE) |
|||
abx134410-100Assays | Abbexa | 100 Assays | EUR 594 |
CD44 Antigen (CD44) Antibody (PE) |
|||
abx134410-50Assays | Abbexa | 50 Assays | EUR 477.6 |
CD44 Antigen (CD44) Antibody (PE) |
|||
abx139278-100tests | Abbexa | 100 tests | EUR 577.2 |
CD44 Antigen (CD44) Antibody (PE) |
|||
abx139282-100tests | Abbexa | 100 tests | EUR 577.2 |
CD44 Antigen (CD44) Antibody (PE) |
|||
abx139286-01mg | Abbexa | 0.1 mg | EUR 410.4 |
CD44 Antigen (CD44) Antibody (RPE) |
|||
abx415397-100tests | Abbexa | 100 tests | EUR 710.4 |
CD44 Antigen (CD44) Antibody (RPE) |
|||
abx415621-100tests | Abbexa | 100 tests | EUR 710.4 |
CD44 Antigen (CD44) Antibody (RPE) |
|||
abx415622-25tests | Abbexa | 25 tests | EUR 376.8 |
CD44 Antigen (CD44) Antibody (RPE) |
|||
abx412740-100tests | Abbexa | 100 tests | EUR 861.6 |
CD44 Antigen (CD44) Antibody (APC) |
|||
abx200296-100tests | Abbexa | 100 tests | EUR 543.6 |
CD44 Antigen (CD44) Antibody (APC) |
|||
20-abx200791 | Abbexa |
|
|
CD44 Antigen (CD44) Antibody (APC) |
|||
abx139279-100tests | Abbexa | 100 tests | EUR 577.2 |
CD44 Antigen (CD44) Antibody (APC) |
|||
abx139283-100tests | Abbexa | 100 tests | EUR 577.2 |
CD44 Antigen (CD44) Antibody (FITC) |
|||
abx414183-01mg | Abbexa | 0.1 mg | EUR 777.6 |
CD44 Antigen (CD44) Antibody (FITC) |
|||
abx415394-01mg | Abbexa | 0.1 mg | EUR 610.8 |
CD44 Antigen (CD44) Antibody (FITC) |
|||
abx415395-50ug | Abbexa | 50 ug | EUR 410.4 |
CD44 Antigen (CD44) Antibody (FITC) |
|||
abx415619-01mg | Abbexa | 0.1 mg | EUR 610.8 |
CD44 Antigen (CD44) Antibody (FITC) |
|||
abx415620-25ug | Abbexa | 25 ug | EUR 326.4 |
CD44 Antigen (CD44) Antibody (FITC) |
|||
abx412636-01mg | Abbexa | 0.1 mg | EUR 610.8 |
CD44 Antigen (CD44) Antibody (FITC) |
|||
abx412637-05mg | Abbexa | 0.5 mg | EUR 861.6 |
CD44 Antigen (CD44) Antibody (FITC) |
|||
abx412638-25ug | Abbexa | 25 ug | EUR 326.4 |
CD44 Antigen (CD44) Antibody (FITC) |
|||
abx412738-01mg | Abbexa | 0.1 mg | EUR 777.6 |
CD44 Antigen (CD44) Antibody (FITC) |
|||
abx413848-01mg | Abbexa | 0.1 mg | EUR 777.6 |
CD44 Antigen (CD44) Antibody (FITC) |
|||
abx200294-100tests | Abbexa | 100 tests | EUR 477.6 |
CD44 Antigen (CD44) Antibody (FITC) |
|||
20-abx200794 | Abbexa |
|
|
CD44 Antigen (CD44) Antibody (FITC) |
|||
abx134409-100Assays | Abbexa | 100 Assays | EUR 526.8 |
CD44 Antigen (CD44) Antibody (FITC) |
|||
abx134409-50Assays | Abbexa | 50 Assays | EUR 410.4 |
CD44 Antigen (CD44) Antibody (FITC) |
|||
abx139281-100tests | Abbexa | 100 tests | EUR 510 |
CD44 Antigen (CD44) Antibody (FITC) |
|||
abx139284-100tests | Abbexa | 100 tests | EUR 510 |
CD44 Antigen (CD44) Antibody (PerCP) |
|||
abx200297-100tests | Abbexa | 100 tests | EUR 861.6 |
CD44 Antigen (CD44) Antibody (PerCP) |
|||
20-abx200796 | Abbexa |
|
|
CD44 Antigen (CD44) Antibody (Biotin) |
|||
abx200298-100ug | Abbexa | 100 ug | EUR 460.8 |
CD44 Antigen (CD44) Antibody (Biotin) |
|||
20-abx200792 | Abbexa |
|
|
CD44 Antigen (CD44) Antibody (Biotin) |
|||
abx139280-01mg | Abbexa | 0.1 mg | EUR 510 |
CD44 Antigen (CD44) Antibody (Biotin) |
|||
abx139288-01mg | Abbexa | 0.1 mg | EUR 376.8 |
Human Leukocyte surface antigen CD44 ELISA Kit(CD44) |
|||
RK04126 | Abclonal | 96 Tests | EUR 726 |
Cow CD44 Antigen (CD44) ELISA Kit |
|||
abx513662-96tests | Abbexa | 96 tests | EUR 1093.2 |
Dog CD44 Antigen (CD44) ELISA Kit |
|||
abx513663-96tests | Abbexa | 96 tests | EUR 1093.2 |
Rat CD44 Antigen (CD44) ELISA Kit |
|||
abx513666-96tests | Abbexa | 96 tests | EUR 904.8 |
Rat CD44 Antigen (CD44) ELISA Kit |
|||
abx256320-96tests | Abbexa | 96 tests | EUR 904.8 |
Rat CD44 antigen, Cd44 ELISA KIT |
|||
ELI-02344r | Lifescience Market | 96 Tests | EUR 1063.2 |
Mouse CD44 Antigen (CD44) ELISA Kit |
|||
abx254787-96tests | Abbexa | 96 tests | EUR 801.6 |
Mouse CD44 antigen, Cd44 ELISA KIT |
|||
ELI-02343m | Lifescience Market | 96 Tests | EUR 1038 |
Recombinant Human CD44 Protein |
|||
RP00973 | Abclonal | 5 μg | EUR 163.2 |
CD44 Antigen (CD44) Antibody (CF-Blue) |
|||
abx200299-100tests | Abbexa | 100 tests | EUR 577.2 |
CD44 Antigen (CD44) Antibody (CF-Blue) |
|||
20-abx200793 | Abbexa |
|
|
Bovine CD44 antigen, CD44 ELISA KIT |
|||
ELI-02340b | Lifescience Market | 96 Tests | EUR 1113.6 |
Canine CD44 antigen, CD44 ELISA KIT |
|||
ELI-02341d | Lifescience Market | 96 Tests | EUR 1113.6 |
CD44 Antigen (CD44) Antibody (PerCP-Cy5.5) |
|||
20-abx200797 | Abbexa |
|
|
CD44 Recombinant Protein (Human) |
|||
RP006367 | ABM | 100 ug | Ask for price |
Rat Cd44(CD44 antigen) ELISA Kit |
|||
ER0342 | FN Test | 96T | EUR 681.12 |
Description: Method of detection: Double Antibody, Sandwich ELISA;Reacts with: Rattus;Sensitivity: 0.188 ng/ml |
Rat Cd44/ CD44 antigen ELISA Kit |
|||
E0180Ra | Sunlong | 1 Kit | EUR 685.2 |
Dog CD44/ CD44 antigen ELISA Kit |
|||
E0019Do | Sunlong | 1 Kit | EUR 860.4 |
Mouse CD44( CD44 antigen) ELISA Kit |
|||
EM0433 | FN Test | 96T | EUR 681.12 |
Description: Method of detection: Double Antibody, Sandwich ELISA;Reacts with: Mus ;Sensitivity: 0.094 ng/ml |
Mouse Cd44/ CD44 antigen ELISA Kit |
|||
E0253Mo | Sunlong | 1 Kit | EUR 685.2 |
Recombinant Human CD166 Antigen (C-Fc) |
|||
CS49-10ug | Novoprotein | 10ug | EUR 96 |
Description: Lyophilized from a 0.2 μm filtered solution of PBS, pH7.4. |
Recombinant Human CD166 Antigen (C-Fc) |
|||
CS49-1mg | Novoprotein | 1mg | EUR 1216.8 |
Description: Lyophilized from a 0.2 μm filtered solution of PBS, pH7.4. |
Recombinant Human CD166 Antigen (C-Fc) |
|||
CS49-500ug | Novoprotein | 500ug | EUR 790.8 |
Description: Lyophilized from a 0.2 μm filtered solution of PBS, pH7.4. |
Recombinant Human CD166 Antigen (C-Fc) |
|||
CS49-50ug | Novoprotein | 50ug | EUR 169.2 |
Description: Lyophilized from a 0.2 μm filtered solution of PBS, pH7.4. |
CD44 Recombinant Protein |
|||
96-107 | ProSci | 0.1 mg | EUR 588.3 |
Description: CD44 antigen is a cell-surface glycoprotein involved in cell–cell interactions, cell adhesion and migration. CD44 is expressed in a large number of mammalian cell types. CD44 is a receptor for hyaluronic acid and can also interact with other ligands, such as osteopontin, collagens, and matrix metalloproteinases (MMPs). CD44 function is controlled by its posttranslational modifications. One critical modification involves discrete sialofucosylations rendering the selectin-binding glycoform of CD44 called HCELL (for Hematopoietic Cell E-selectin/L-selectin Ligand). CD44 participates in a wide variety of cellular functions including lymphocyte activation, recirculation and homing, hematopoiesis, and tumor metastasis. Transcripts for this gene undergo complex alternative splicing that results in many functionally distinct isoforms. |
CD44 Recombinant Protein |
|||
96-624 | ProSci | 0.1 mg | EUR 588.3 |
Description: CD44 antigen is a cell-surface glycoprotein involved in cell–cell interactions, cell adhesion and migration. CD44 is expressed in a large number of mammalian cell types. CD44 is a receptor for hyaluronic acid and can also interact with other ligands, such as osteopontin, collagens, and matrix metalloproteinases (MMPs). CD44 function is controlled by its posttranslational modifications. One critical modification involves discrete sialofucosylations rendering the selectin-binding glycoform of CD44 called HCELL (for Hematopoietic Cell E-selectin/L-selectin Ligand). CD44 participates in a wide variety of cellular functions including lymphocyte activation, recirculation and homing, hematopoiesis, and tumor metastasis. Transcripts for this gene undergo complex alternative splicing that results in many functionally distinct isoforms. |
CD44 Recombinant Protein |
|||
91-517 | ProSci | 0.05 mg | EUR 556.8 |
Description: CD44 is a cell-surface receptor for hyaluronic acid and also interacts with other ligands, such as osteopontin, collagens, and matrix metalloproteinases. A large number of CD44 isoforms can be generated by the insertion of different combinations of at least nine exons. Increased CD44 antigen is associated with relapses in non-small cell lung cancers. Furthermore, an increasing quantity of evidence suggests that CD44 has various functions related to inflammatory disease. CD44 deficiency induces severe liver injury. CD44-hyaluronate mediates in lymphocyte T and monocyte adhesion to the endothelium, stimulates proinflammatory cytokine release from macrophages and participates in dedifferentiation phenotype of smooth muscle cells from contractile state to synthetic one. |
CD44 Recombinant Protein |
|||
91-888 | ProSci | 0.05 mg | EUR 588.3 |
Description: CD44 is a cell-surface receptor for hyaluronic acid and also interacts with other ligands, such as osteopontin, collagens, and matrix metalloproteinases. A large number of CD44 isoforms can be generated by the insertion of different combinations of at least nine exons. Increased CD44 antigen is associated with relapses in non-small cell lung cancers. Furthermore, an increasing quantity of evidence suggests that CD44 has various functions related to inflammatory disease. CD44 deficiency induces severe liver injury. CD44-hyaluronate mediates in lymphocyte T and monocyte adhesion to the endothelium, stimulates proinflammatory cytokine release from macrophages and participates in dedifferentiation phenotype of smooth muscle cells from contractile state to synthetic one. |
Recombinant Human CD44/MIC4 (C-Fc) |
|||
CX13-10ug | Novoprotein | 10ug | EUR 175.2 |
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB,150mM NaCl,pH7.4. |
Recombinant Human CD44/MIC4 (C-Fc) |
|||
CX13-1mg | Novoprotein | 1mg | EUR 2739.6 |
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB,150mM NaCl,pH7.4. |
Recombinant Human CD44/MIC4 (C-Fc) |
|||
CX13-500ug | Novoprotein | 500ug | EUR 1935.6 |
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB,150mM NaCl,pH7.4. |
Recombinant Human CD44/MIC4 (C-Fc) |
|||
CX13-50ug | Novoprotein | 50ug | EUR 363.6 |
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB,150mM NaCl,pH7.4. |
Recombinant human B-lymphocyte antigen CD19 |
|||
P1837 | FN Test | 100ug | Ask for price |
Description: Recombinant protein for human B-lymphocyte antigen CD19 |
Recombinant human B-lymphocyte antigen CD20 |
|||
P2398 | FN Test | 100ug | Ask for price |
Description: Recombinant protein for human B-lymphocyte antigen CD20 |
CD44 Antigen Phospho-Ser706 (CD44 pS706) Antibody |
|||
20-abx327356 | Abbexa |
|
|
Cd44 ELISA Kit| Rat CD44 antigen ELISA Kit |
|||
EF017212 | Lifescience Market | 96 Tests | EUR 826.8 |
CD44 ELISA Kit| Mouse CD44 antigen ELISA Kit |
|||
EF013083 | Lifescience Market | 96 Tests | EUR 826.8 |
CD44 recombinant monoclonal antibody |
|||
A5070 | Bimake | 100ul X 3 | EUR 714 |
Description: A recombinant monoclonal antibody from rabbit against human CD44 for WB,ELISA |
Recombinant Human CD226 Antigen/DNAM-1/CD226 (C-Fc) |
|||
CS90-10ug | Novoprotein | 10ug | EUR 151.2 |
Description: Lyophilized from a 0.2 μm filtered solution of PBS, pH7.4. |
Recombinant Human CD226 Antigen/DNAM-1/CD226 (C-Fc) |
|||
CS90-1mg | Novoprotein | 1mg | EUR 1581.6 |
Description: Lyophilized from a 0.2 μm filtered solution of PBS, pH7.4. |
Recombinant Human CD226 Antigen/DNAM-1/CD226 (C-Fc) |
|||
CS90-500ug | Novoprotein | 500ug | EUR 1155.6 |
Description: Lyophilized from a 0.2 μm filtered solution of PBS, pH7.4. |
Recombinant Human CD226 Antigen/DNAM-1/CD226 (C-Fc) |
|||
CS90-50ug | Novoprotein | 50ug | EUR 333.6 |
Description: Lyophilized from a 0.2 μm filtered solution of PBS, pH7.4. |
Recombinant Human CD226 Antigen/DNAM-1/CD226 (C-6His) |
|||
CS89-10ug | Novoprotein | 10ug | EUR 151.2 |
Description: Lyophilized from a 0.2 μm filtered solution of PBS, pH7.4. |
Recombinant Human CD226 Antigen/DNAM-1/CD226 (C-6His) |
|||
CS89-1mg | Novoprotein | 1mg | EUR 1581.6 |
Description: Lyophilized from a 0.2 μm filtered solution of PBS, pH7.4. |
Recombinant Human CD226 Antigen/DNAM-1/CD226 (C-6His) |
|||
CS89-500ug | Novoprotein | 500ug | EUR 1155.6 |
Description: Lyophilized from a 0.2 μm filtered solution of PBS, pH7.4. |
Recombinant Human CD226 Antigen/DNAM-1/CD226 (C-6His) |
|||
CS89-50ug | Novoprotein | 50ug | EUR 333.6 |
Description: Lyophilized from a 0.2 μm filtered solution of PBS, pH7.4. |
Recombinant Human Early Activation Antigen CD69/CD69 (N-8His) |
|||
CU12-10ug | Novoprotein | 10ug | EUR 187.2 |
Description: Lyophilized from a 0.2 μm filtered solution of PBS, pH7.4. |
Recombinant Human Early Activation Antigen CD69/CD69 (N-8His) |
|||
CU12-1mg | Novoprotein | 1mg | EUR 2739.6 |
Description: Lyophilized from a 0.2 μm filtered solution of PBS, pH7.4. |
Recombinant Human Early Activation Antigen CD69/CD69 (N-8His) |
|||
CU12-500ug | Novoprotein | 500ug | EUR 1935.6 |
Description: Lyophilized from a 0.2 μm filtered solution of PBS, pH7.4. |
Recombinant Human Early Activation Antigen CD69/CD69 (N-8His) |
|||
CU12-50ug | Novoprotein | 50ug | EUR 442.8 |
Description: Lyophilized from a 0.2 μm filtered solution of PBS, pH7.4. |
CD44 Recombinant Protein (Rat) |
|||
RP193973 | ABM | 100 ug | Ask for price |
Recombinant Human CD94/Natural Killer Cells Antigen CD94 Protein |
|||
RP00567 | Abclonal | 10 μg | EUR 219.6 |
CD44 Recombinant Protein (Mouse) |
|||
RP122609 | ABM | 100 ug | Ask for price |
CD44 Recombinant Protein (Mouse) |
|||
RP122612 | ABM | 100 ug | Ask for price |
CD44 Recombinant Protein (Mouse) |
|||
RP122615 | ABM | 100 ug | Ask for price |
CD44 Recombinant Protein (Mouse) |
|||
RP122618 | ABM | 100 ug | Ask for price |
CD44 Recombinant Protein (Mouse) |
|||
RP122621 | ABM | 100 ug | Ask for price |
CD44 Recombinant Protein (Mouse) |
|||
RP122624 | ABM | 100 ug | Ask for price |
Recombinant human T-lymphocyte activation antigen CD80 |
|||
P2350 | FN Test | 100ug | Ask for price |
Description: Recombinant protein for human T-lymphocyte activation antigen CD80 |
Recombinant Human Natural Killer Cells Antigen CD94/CD94 (N-6His) |
|||
CA63-10ug | Novoprotein | 10ug | EUR 187.2 |
Description: Lyophilized from a 0.2 μm filtered solution of PBS, pH7.4. |
Recombinant Human Natural Killer Cells Antigen CD94/CD94 (N-6His) |
|||
CA63-1mg | Novoprotein | 1mg | EUR 2739.6 |
Description: Lyophilized from a 0.2 μm filtered solution of PBS, pH7.4. |
Recombinant Human Natural Killer Cells Antigen CD94/CD94 (N-6His) |
|||
CA63-500ug | Novoprotein | 500ug | EUR 1935.6 |
Description: Lyophilized from a 0.2 μm filtered solution of PBS, pH7.4. |
Recombinant Human Natural Killer Cells Antigen CD94/CD94 (N-6His) |
|||
CA63-50ug | Novoprotein | 50ug | EUR 442.8 |
Description: Lyophilized from a 0.2 μm filtered solution of PBS, pH7.4. |
Recombinant Human CD44 Protein (aa 1-220) [Fc] |
|||
VAng-Cr3931-100g | Creative Biolabs | 100 µg | EUR 2024.4 |
Description: Recombinant Human CD44 Protein (Met 1-Pro 220) fused with a Fc tag at C-terminus was expressed in HEK293 Cells, with a molecular weight of 49.1 kDa. (Accession ID: P16070-1) |
Recombinant Human CD44 Protein (aa 1-220) [Fc] |
|||
VAng-Cr3931-50g | Creative Biolabs | 50 µg | EUR 1232.4 |
Description: Recombinant Human CD44 Protein (Met 1-Pro 220) fused with a Fc tag at C-terminus was expressed in HEK293 Cells, with a molecular weight of 49.1 kDa. (Accession ID: P16070-1) |
Recombinant Human CD44 Protein (aa 1-220) [His] |
|||
VAng-Cr3930-100g | Creative Biolabs | 100 µg | EUR 2024.4 |
Description: Recombinant Human CD44 Protein (Met 1-Pro 220) fused with a His tag at C-terminus was expressed in HEK293 Cells, with a molecular weight of 23.4 kDa. (Accession ID: P16070-1) |
Recombinant Human CD44 Protein (aa 1-220) [His] |
|||
VAng-Cr3930-50g | Creative Biolabs | 50 µg | EUR 1232.4 |
Description: Recombinant Human CD44 Protein (Met 1-Pro 220) fused with a His tag at C-terminus was expressed in HEK293 Cells, with a molecular weight of 23.4 kDa. (Accession ID: P16070-1) |
Recombinant Human CD99 Antigen-Like Protein 2/CD99L2 (C-Fc) |
|||
CI75-10ug | Novoprotein | 10ug | EUR 175.2 |
Description: Lyophilized from a 0.2 μm filtered solution of PBS,pH7.4. |
Recombinant Human CD99 Antigen-Like Protein 2/CD99L2 (C-Fc) |
|||
CI75-1mg | Novoprotein | 1mg | EUR 2739.6 |
Description: Lyophilized from a 0.2 μm filtered solution of PBS,pH7.4. |
Recombinant Human CD99 Antigen-Like Protein 2/CD99L2 (C-Fc) |
|||
CI75-500ug | Novoprotein | 500ug | EUR 1935.6 |
Description: Lyophilized from a 0.2 μm filtered solution of PBS,pH7.4. |
Recombinant Human CD99 Antigen-Like Protein 2/CD99L2 (C-Fc) |
|||
CI75-50ug | Novoprotein | 50ug | EUR 363.6 |
Description: Lyophilized from a 0.2 μm filtered solution of PBS,pH7.4. |
Recombinant Human Leukocyte Surface Antigen CD47 (C-Fc-Avi) |
|||
CU01-10ug | Novoprotein | 10ug | EUR 151.2 |
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB, 150mM NaCl, pH7.4. |
Recombinant Human Leukocyte Surface Antigen CD47 (C-Fc-Avi) |
|||
CU01-1mg | Novoprotein | 1mg | EUR 1581.6 |
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB, 150mM NaCl, pH7.4. |
Recombinant Human Leukocyte Surface Antigen CD47 (C-Fc-Avi) |
|||
CU01-500ug | Novoprotein | 500ug | EUR 1155.6 |
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB, 150mM NaCl, pH7.4. |
Recombinant Human Leukocyte Surface Antigen CD47 (C-Fc-Avi) |
|||
CU01-50ug | Novoprotein | 50ug | EUR 333.6 |
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB, 150mM NaCl, pH7.4. |
Recombinant Human CD99 Antigen-Like Protein 2/CD99L2 (C-6His) |
|||
CA67-10ug | Novoprotein | 10ug | EUR 187.2 |
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB,150mM NaCl,pH7.4. |
Recombinant Human CD99 Antigen-Like Protein 2/CD99L2 (C-6His) |
|||
CA67-1mg | Novoprotein | 1mg | EUR 2739.6 |
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB,150mM NaCl,pH7.4. |
Recombinant Human CD99 Antigen-Like Protein 2/CD99L2 (C-6His) |
|||
CA67-500ug | Novoprotein | 500ug | EUR 1935.6 |
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB,150mM NaCl,pH7.4. |
Recombinant Human CD99 Antigen-Like Protein 2/CD99L2 (C-6His) |
|||
CA67-50ug | Novoprotein | 50ug | EUR 442.8 |
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB,150mM NaCl,pH7.4. |
Recombinant Human Leukocyte Surface Antigen CD47/IAP/OA3 (C-Fc) |
|||
CG18-10ug | Novoprotein | 10ug | EUR 242.4 |
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB,150mM NaCl,pH7.4. |
Recombinant Human Leukocyte Surface Antigen CD47/IAP/OA3 (C-Fc) |
|||
CG18-1mg | Novoprotein | 1mg | EUR 2983.2 |
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB,150mM NaCl,pH7.4. |
Recombinant Human Leukocyte Surface Antigen CD47/IAP/OA3 (C-Fc) |
|||
CG18-500ug | Novoprotein | 500ug | EUR 2106 |
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB,150mM NaCl,pH7.4. |
Recombinant Human Leukocyte Surface Antigen CD47/IAP/OA3 (C-Fc) |
|||
CG18-50ug | Novoprotein | 50ug | EUR 595.2 |
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB,150mM NaCl,pH7.4. |
CD44 antigen isoform 4 antibody |
|||
22981-100ul | SAB | 100ul | EUR 468 |
ELISA kit for Rat CD44 antigen |
|||
EK2102 | SAB | 96 tests | EUR 663.6 |
Description: Enzyme-linked immunosorbent assay kit for quantification of Rat CD44 antigen in samples from serum, plasma, tissue homogenates and other biological fluids. |
CD90 Thy-1 Cell Surface Antigen Human Recombinant Protein |
|||
PROTP04216 | BosterBio | Regular: 5ug | EUR 380.4 |
Description: CD90 Human Recombinant produced in Sf9 Baculovirus cells is a single, glycosylated polypeptide chain containing 117 amino acids (20-130a.a.) and having a molecular mass of 13.3kDa (Molecular size on SDS-PAGE will appear at approximately 13.5-28kDa).;CD90 is fused with a 6 amino acids His tag at C-Terminus and purified by proprietary chromatographic techniques. |
Recombinant Mouse CD6 antigen/CD6 (C-6His) |
|||
CU62-10ug | Novoprotein | 10ug | EUR 120 |
Description: Lyophilized from a 0.2 μm filtered solution of PBS, pH7.4. |
Recombinant Mouse CD6 antigen/CD6 (C-6His) |
|||
CU62-1mg | Novoprotein | 1mg | EUR 1216.8 |
Description: Lyophilized from a 0.2 μm filtered solution of PBS, pH7.4. |
Recombinant Mouse CD6 antigen/CD6 (C-6His) |
|||
CU62-500ug | Novoprotein | 500ug | EUR 973.2 |
Description: Lyophilized from a 0.2 μm filtered solution of PBS, pH7.4. |
Recombinant Mouse CD6 antigen/CD6 (C-6His) |
|||
CU62-50ug | Novoprotein | 50ug | EUR 242.4 |
Description: Lyophilized from a 0.2 μm filtered solution of PBS, pH7.4. |
Recombinant Human CD44/ HCAM Protein, His-SUMO, E.coli-1mg |
|||
QP5788-ec-1mg | EnQuireBio | 1mg | EUR 1958.4 |
Recombinant Human B-Cell Differentiation Antigen CD72/Lyb‑2 (N-Trx, 6His) |
|||
CF13-10ug | Novoprotein | 10ug | EUR 242.4 |
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB,150mM NaCl,pH7.4. |
Recombinant Human B-Cell Differentiation Antigen CD72/Lyb‑2 (N-Trx, 6His) |
|||
CF13-1mg | Novoprotein | 1mg | EUR 2983.2 |
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB,150mM NaCl,pH7.4. |
Recombinant Human B-Cell Differentiation Antigen CD72/Lyb‑2 (N-Trx, 6His) |
|||
CF13-500ug | Novoprotein | 500ug | EUR 2106 |
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB,150mM NaCl,pH7.4. |
Recombinant Human B-Cell Differentiation Antigen CD72/Lyb‑2 (N-Trx, 6His) |
|||
CF13-50ug | Novoprotein | 50ug | EUR 595.2 |
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB,150mM NaCl,pH7.4. |
Recombinant Human CD44/ HCAM Protein, His-SUMO, E.coli-10ug |
|||
QP5788-ec-10ug | EnQuireBio | 10ug | EUR 240 |
Recombinant Human CD44/ HCAM Protein, His-SUMO, E.coli-50ug |
|||
QP5788-ec-50ug | EnQuireBio | 50ug | EUR 315.6 |
Recombinant Human CD44/ HCAM Protein, His-SUMO, E.coli-100ug |
|||
QP5788-ec-100ug | EnQuireBio | 100ug | EUR 489.6 |
Recombinant Human CD44/ HCAM Protein, His-SUMO, E.coli-200ug |
|||
QP5788-ec-200ug | EnQuireBio | 200ug | EUR 760.8 |
Recombinant Human CD44/ HCAM Protein, His-SUMO, E.coli-500ug |
|||
QP5788-ec-500ug | EnQuireBio | 500ug | EUR 1272 |
Recombinant CD5 Antigen Like Protein (CD5L) |
|||
4-RPL300Hu01 | Cloud-Clone |
|
|
Description: Recombinant Human CD5 Antigen Like Protein expressed in: E.coli |
Recombinant CD5 Antigen Like Protein (CD5L) |
|||
4-RPL300Mu01 | Cloud-Clone |
|
|
Description: Recombinant Mouse CD5 Antigen Like Protein expressed in: E.coli |
Recombinant CD5 Antigen Like Protein (CD5L) |
|||
4-RPL300Ra01 | Cloud-Clone |
|
|
Description: Recombinant Rat CD5 Antigen Like Protein expressed in: E.coli |
Recombinant Human Bone Marrow Stromal Antigen 2/BST2/Tetherin/CD317 (C-6His) |
|||
CA75-10ug | Novoprotein | 10ug | EUR 187.2 |
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB,150mM NaCl,pH7.4. |
Recombinant Human Bone Marrow Stromal Antigen 2/BST2/Tetherin/CD317 (C-6His) |
|||
CA75-1mg | Novoprotein | 1mg | EUR 2739.6 |
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB,150mM NaCl,pH7.4. |
Recombinant Human Bone Marrow Stromal Antigen 2/BST2/Tetherin/CD317 (C-6His) |
|||
CA75-500ug | Novoprotein | 500ug | EUR 1935.6 |
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB,150mM NaCl,pH7.4. |
Recombinant Human Bone Marrow Stromal Antigen 2/BST2/Tetherin/CD317 (C-6His) |
|||
CA75-50ug | Novoprotein | 50ug | EUR 442.8 |
Description: Lyophilized from a 0.2 μm filtered solution of 20mM PB,150mM NaCl,pH7.4. |
Recombinant Human T-lymphocyte Surface Antigen Ly-9/SLAMF3/CD229 (C-6His) |
|||
CC37-10ug | Novoprotein | 10ug | EUR 169.2 |
Description: Lyophilized from a 0.2 μm filtered solution of PBS, pH7.4. |
Recombinant Human T-lymphocyte Surface Antigen Ly-9/SLAMF3/CD229 (C-6His) |
|||
CC37-1mg | Novoprotein | 1mg | EUR 2008.8 |
Description: Lyophilized from a 0.2 μm filtered solution of PBS, pH7.4. |
Recombinant Human T-lymphocyte Surface Antigen Ly-9/SLAMF3/CD229 (C-6His) |
|||
CC37-500ug | Novoprotein | 500ug | EUR 1423.2 |
Description: Lyophilized from a 0.2 μm filtered solution of PBS, pH7.4. |
Recombinant Human T-lymphocyte Surface Antigen Ly-9/SLAMF3/CD229 (C-6His) |
|||
CC37-50ug | Novoprotein | 50ug | EUR 363.6 |
Description: Lyophilized from a 0.2 μm filtered solution of PBS, pH7.4. |
CD99 Antigen-Like Protein 2 Recombinant Protein |
|||
91-768 | ProSci | 0.05 mg | EUR 651.3 |
Description: CD99 Antigen-Like Protein 2 (CD99L2) belongs to the CD99 family. CD99L2 is a single-pass type I membrane protein and expressed in many tissues, with low expression in thymus. CD99L2 plays a role in a late step of leukocyte extravasation helping cells to overcome the endothelial basement membrane. CD99L2 and CD99 are involved in trans-endothelial migration of neutrophils in vitro and in the recruitment of neutrophils into inflamed peritoneum. A similar protein in mouse functions as an adhesion molecule during leukocyte extravasation. Alternate splicing results in multiple transcript variants. |
CD99 antigen-like protein 2 Recombinant Protein |
|||
92-380 | ProSci | 0.05 mg | EUR 588.3 |
Description: CD99 Antigen-Like Protein 2 (CD99L2) belongs to the CD99 family. CD99L2 is a single-pass type I membrane protein and expressed in many tissues, with low expression in thymus. CD99L2 plays a role in a late step of leukocyte extravasation helping cells to overcome the endothelial basement membrane. CD99L2 and CD99 are involved in trans-endothelial migration of neutrophils in vitro and in the recruitment of neutrophils into inflamed peritoneum. A similar protein in mouse functions as an adhesion molecule during leukocyte extravasation. Alternate splicing results in multiple transcript variants. |
Recombinant human RHD antigen |
|||
P1958 | FN Test | 100ug | Ask for price |
Description: Recombinant protein for human RHD antigen |
Recombinant CD44 Protein (Gln 21-Pro 220) [Fc] |
|||
VAng-1320Lsx-100g | Creative Biolabs | 100 µg | EUR 885.6 |
Description: Human CD44, Fc tag, is expressed in HEK 293 cells. (Uniprot ID: AAH04372) |
×
Right here, we concentrate on the latest advances of the novel CoV, and talk about its genomic similarity with different CoVs, transmission, animal mannequin and scientific therapy of coronavirus illness 2019 (COVID-19) induced by SARS-CoV-2, which assist epidemic prevention and management, and information therapy methods.
Tags: dna dna ancestry dna block dna bts dna genetics dna hr block dna hrblock login dna lyrics dna motoring dna painter dna productions dna replication dna song dna study slavery dna template sequence dna template slippage dna template strand dna template strand and non-template strand dna template strand and rna strand dna template strand coding strand dna template strand definition dna template strand meaning dna template strand mrna dna template strand read in what direction dna template strand role in transcription dna template strand sequencing dna template strand to amino acid translation dna template strand transcription dna template strand translation exosomes 5g exosomes and chf exosomes and coronavirus exosomes and ed exosomes and ms exosomes and ra exosomes and viruses exosomes are virus exosomes dr kaufman exosomes for delivery exosomes for hair exosomes for hair loss exosomes msc exosomes nj exosomes tem exosomes therapy exosomes treatment gels iga gels iga st henry ohio gels kitchen gelsemium gelsemium homeopathic gelsemium sempervirens gelsenkirchen gelsey kirkland gelsey kirkland 2020 gelsolin gelson’s instacart gelson’s market